These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9830263)

  • 21. Long-Term Follow-up of Onychomycosis Patients Treated With Efinaconazole.
    Pollak RA; Ilie C
    J Drugs Dermatol; 2017 Dec; 16(12):1269-1273. PubMed ID: 29240863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis.
    Elewski B; Pollak R; Ashton S; Rich P; Schlessinger J; Tavakkol A
    Br J Dermatol; 2012 Feb; 166(2):389-98. PubMed ID: 21967490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in dermatophytic onychomycosis.
    Paul C; Coustou D; Lahfa M; Bulai-Livideanu C; Doss N; Mokthar I; Turki H; Nouira R; Fazaa B; Ben Osman A; Zourabichvili O; Cazeau C; Coubetergues H; Picot S; Bienvenu AL; Voisard JJ
    Dermatology; 2013; 227(2):157-64. PubMed ID: 24051622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs.
    Elewski BE; Ghannoum MA; Mayser P; Gupta AK; Korting HC; Shouey RJ; Baker DR; Rich PA; Ling M; Hugot S; Damaj B; Nyirady J; Thangavelu K; Notter M; Parneix-Spake A; Sigurgeirsson B
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):287-94. PubMed ID: 22181693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.
    Elewski BE; Rich P; Pollak R; Pariser DM; Watanabe S; Senda H; Ieda C; Smith K; Pillai R; Ramakrishna T; Olin JT
    J Am Acad Dermatol; 2013 Apr; 68(4):600-608. PubMed ID: 23177180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of 4 weeks topical bifonazole treatment for onychomycosis after nail ablation with 40% urea: a double-blind, randomized, placebo-controlled multicenter study.
    Tietz HJ; Hay R; Querner S; Delcker A; Kurka P; Merk HF
    Mycoses; 2013 Jul; 56(4):414-21. PubMed ID: 23586591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the efficacy and safety of tavaborole topical solution, 5%, in the treatment of onychomycosis of the toenail in adults: a pooled analysis of an 8-week, post-study follow-up from two randomized phase 3 studies.
    Gupta AK; Hall S; Zane LT; Lipner SR; Rich P
    J Dermatolog Treat; 2018 Feb; 29(1):44-48. PubMed ID: 28521541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis.
    Sigurgeirsson B; van Rossem K; Malahias S; Raterink K
    J Am Acad Dermatol; 2013 Sep; 69(3):416-25. PubMed ID: 23706639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
    Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
    J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.
    Sigurgeirsson B; Elewski BE; Rich PA; Opper C; Cai B; Nyirady J; Bakshi R
    J Dermatolog Treat; 2006; 17(1):38-44. PubMed ID: 16467022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized treatment duration-finding study of terbinafine in onychomycosis.
    van der Schroeff JG; Cirkel PK; Crijns MB; Van Dijk TJ; Govaert FJ; Groeneweg DA; Tazelaar DJ; De Wit RF; Wuite J
    Br J Dermatol; 1992 Feb; 126 Suppl 39():36-9. PubMed ID: 1531927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis.
    Sigurgeirsson B; Billstein S; Rantanen T; Ruzicka T; di Fonzo E; Vermeer BJ; Goodfield MJ; Evans EG
    Br J Dermatol; 1999 Nov; 141 Suppl 56():5-14. PubMed ID: 10730908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trial.
    Lesher JL; Babel DE; Stewart DM; Jones TM; Kaminester L; Goldman M; Weintraub JS
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S20-4. PubMed ID: 9039201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Butenafine hydrochloride (Mentax) cream for the treatment of hyperkeratotic type tinea pedis and its transfer into the horny layer, with or without concomitant application of 20% urea ointment (Keratinamin).
    Tanuma H; Doi M; Ohta Y; Abe M; Kume H; Mukai H; Katsuoka K
    Mycoses; 2001; 44(7-8):287-99. PubMed ID: 11714064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis?
    Elewski BE; Cantrell W; Lin T
    J Drugs Dermatol; 2018 Feb; 17(2):175-178. PubMed ID: 29462225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Factors for Complete Cure Following Treatment of Mild and Moderate Toenail Onychomycosis With Efinaconazole Topical Solution 10.
    Jellinek NJ; Korotzer A
    J Drugs Dermatol; 2015 Aug; 14(8):871-5. PubMed ID: 26267732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.
    Evans EG; Sigurgeirsson B
    BMJ; 1999 Apr; 318(7190):1031-5. PubMed ID: 10205099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy of continuous and pulse dose terbinafine regimes in toenail dermatophytosis: A randomized double-blind trial.
    Yadav P; Singal A; Pandhi D; Das S
    Indian J Dermatol Venereol Leprol; 2015; 81(4):363-9. PubMed ID: 26087080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short term treatment of dermatophyte onychomycosis with terbinafine.
    Goodfield MJ; Andrew L; Evans EG
    BMJ; 1992 May; 304(6835):1151-4. PubMed ID: 1392793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.